Print Page     Close Window     

SEC Filings

8-K
SERES THERAPEUTICS, INC. filed this Form 8-K on 10/16/2017
Entire Document
 


Slide 6

Multiple FMT studies provide proof-of-concept of clinical benefit in patients with Ulcerative Colitis Subject A, Baseline Subject A, 8-wk post FMT Selected references: Paramsothy et al. Lancet, 2017; Moayyedi et al. Gastroenterology, 2015; Review article: Costello et al. Alimentary Pharmacology & Therapeutics, 2017.


© Seres Therapeutics. All Rights Reserved.